Niva Bupa Health Insurance Company Intrinsic Value
Niva Bupa Health Insurance Company (NIVABUPA) median intrinsic value is ₹27.19 from 3 valuation models (range ₹21–₹123), vs current price ₹74.31 — -63.4% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Niva Bupa Health Insurance Com share price chart.
NIVABUPA Valuation Methods Summary — DCF, Graham Number & P/E
Niva Bupa Health Insurance Company intrinsic value across 3 models vs current price ₹74.31 — upside/downside and value range per method. Browse NIVABUPA quarterly financials for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹20.67 | ₹18.60 - ₹22.74 | -72.2% | Book Value/Share: ₹20.67, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹27.19 | ₹24.47 - ₹29.91 | -63.4% | Revenue/Share: ₹33.98, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹122.97 | ₹98.38 - ₹147.56 | +65.5% | CF Growth: 15.0%, Discount: 15% |
NIVABUPA Intrinsic Value vs Market Price — All Valuation Models
Niva Bupa Health Insurance Company fair value range ₹21–₹123 vs current market price ₹74.31 across 3 valuation models. Compare with Niva Bupa Health Insurance Com valuation methods to assess whether the stock is under or overvalued.
NIVABUPA Intrinsic Value Analysis — Undervalued or Overvalued?
Niva Bupa Health Insurance Company median intrinsic value ₹27.19, current price ₹74.31 — Trading Above Calculated Value by 63.4%, margin of safety -100.0%.
What is the intrinsic value of NIVABUPA?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Niva Bupa Health Insurance Company (NIVABUPA) is ₹27.19 (median value). With the current market price of ₹74.31, this represents a -63.4% variance from our estimated fair value.
The valuation range spans from ₹20.67 to ₹122.97, indicating ₹20.67 - ₹122.97.
Is NIVABUPA undervalued or overvalued?
Based on our multi-method analysis, Niva Bupa Health Insurance Company (NIVABUPA) appears to be trading above calculated value by approximately 63.4%.
NIVABUPA Financial Health — Key Ratios vs Industry Benchmarks
Niva Bupa Health Insurance Company financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | -3.22 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -0.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -11.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.88x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
NIVABUPA Cash Flow Quality — Operating & Free Cash Flow
Niva Bupa Health Insurance Company operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1,654 Cr | ₹480 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹813 Cr | ₹-128 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹593 Cr | ₹179 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹338 Cr | ₹-24 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹257 Cr | ₹70 Cr | Positive Free Cash Flow | 7/10 |